| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.09B | — | +9.3% |
| Cost of Revenue | $576.2M | — | +4.8% |
| R&D Expense | $103.4M | — | -6.5% |
| SG&A Expense | $849.9M | — | +12.0% |
| Operating Income | $373.2M | — | +27.7% |
| Pre-tax Income | $301.3M | — | +31.6% |
| Income Tax | $63.0M | — | +35.5% |
| Net Income | $238.1M | — | +30.8% |
| EPS (Basic) | $1.22 | — | +32.6% |
| EPS (Diluted) | $1.22 | — | +34.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $424.2M | -28.3% | -69.4% |
| Accounts Receivable | $1.73B | +1.4% | +12.7% |
| Inventory | $2.25B | -1.7% | +0.1% |
| Current Assets | $4.96B | -3.1% | -11.2% |
| Total Assets | $22.72B | -1.6% | +2.4% |
| Current Liabilities | $2.86B | +10.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $359.4M | — | -6.1% |
| Capital Expenditures | $36.3M | — | -18.6% |
| Investing Cash Flow | -$159.0M | — | -50.0% |
| Financing Cash Flow | -$369.2M | — | -164.2% |
| Free Cash Flow | $323.1M | — | -4.5% |
| +24.8% |
| Long-term Debt | $6.30B | -9.2% | -4.3% |
| Total Liabilities | $10.04B | -3.3% | +2.7% |
| Stockholders' Equity | $12.67B | -0.2% | +2.2% |